Generically known as aprotinin, Trasylol is an injectable protein that is administered during complicated surgeries, such as heart or liver surgery, to slow bleeding and reduce the need for blood transfusions. Although it is effective at slowing down the breakdown of blood clots, in 2007, Trasylol was temporarily withdrawn from the U.S. market due to findings that this medication could potentially increase the risk of surgical complications and death.

Trasylol was soon reintroduced to the public. However, less than a year later in May 2008, Trasylol was permanently withdrawn from the market as a result of follow up studies that confirmed its dangers.

FDA approved in 1994, Trasylol was manufactured by Bayer Healthcare. Up until it was pulled from the market, was used in approximately 33 percent of all cardiac bypass surgeries in the U.S. In fact, researchers estimate that about 22,000 lives could have been saved had Trasylol been pulled from the shelves upon the first indications of its dangers.

Trasylol Side Effects

The most severe Trasylol side effects include:

• Blood clots
• Congestive heart failure
• Encephalopathy, a brain disease that causes serious cognitive dysfunction
• Heart attack
• Liver and/or kidney damage
• Liver and/or kidney failure
• Pulmonary embolism, life-threatening blood clots in the lungs
• Severe allergic reactions
• Stroke

Symptoms of such serious Trasylol side effects may include any combination of:

• Asthma or other breathing difficulties
• Chest pain
• Decreased urination
• Dizziness
• Fainting and/or lightheadedness
• Hives and/or skin rash
• Inflammation of hands, feet or legs
• Irregular heartbeat
• Numbness affecting a particular side of the body
• Severe headache
• Sudden weight gain
• Vision and/or speech impairments
• Vomiting

Help for Injured Patients

If you or a loved one has been injured by Trasylol, contact Gacovino, Lake and Associates for a thorough evaluation of your case. Our defective drug attorneys will investigate the details of your case to determine the best legal strategy.

• Accutane®
• Ambien Drug Information
• Avandia
• Chantix Drug Information
• Darvocet® Drug Information
• Darvon® Pulled from Market
• Denture Cream
• Digitek Drug Information
• Epilepsy Drugs
• Fleet Phospho-Soda
• Fosamax Drug Information
• Heparin Drug Information
• Hydroxycut Drug Information
• Ketek Drug Information
• Levaquin Drug Information
• Mirapex Drug Information
• MRI Contrast Dye
• Neurontin Drug Information
• Paxil Birth Defects
• Prempro Drug Information
• Prozac Drug Information
• Raptiva Drug Information
• Reglan Drug Information
• Remicade Drug Information
• Seroquel
• Strattera Drug Information
• Trasylol Drug Information
• Wellbutrin Drug Information
• Yaz Drug Information

News

• January 30, 2012
  8 Tips for Safe Use of an Electric Space Heater
• January 27, 2012
  10 Fireplace Safety Tips
• January 25, 2012
  Statins Found to Increase Risk of Diabetes in Postmenopausal Women
• January 23, 2012
  Risk of Serious Bleeding from Aspirin May Not Be Worth the Benefits
• January 20, 2012
  Investigators Find Most Hospital Errors Are Never Reported
• January 19, 2012
  Drug Error Alert: Over-the-Counter Drugs May Be Mixed with Prescriptions
• January 17, 2012
  Recommendations for Lowering Levels of Lead Poisoning Standards
• January 16, 2012
  FDA Ordering Risk Study for Implantable Surgical Mesh
• January 15, 2012
  4 Ways to Prevent an Overdose of Liquid Acetaminophen in Younger Children
• January 14, 2012
  FDA Questioned on Missing Data Concerning Safety of Silicone Breast Implants